Cytokinetics (CYTK) Change in Acquisitions & Divestments (2010 - 2026)

Cytokinetics (CYTK) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $257.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 6.45% year-over-year to $257.9 million; the TTM figure through Mar 2026 stood at -$11.8 million (down 101.4% YoY), while the FY2025 annual figure was $6.0 million, down 99.19% from the prior year.
• Change in Acquisitions & Divestments rose to $257.9 million in Q1 2026 per CYTK's latest filing, from $8000.0 in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $744.2 million in Q4 2024 and bottomed at -$269.7 million in Q2 2025.
• Historically, Change in Acquisitions & Divestments has averaged $107.8 million across 5 years, with a median of $136.0 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments plunged 280.63% — and 2024, when it jumped 37211350.0%.
• Cytokinetics' Change in Acquisitions & Divestments stood at $157.6 million in 2022, then plunged by 100.0% to -$2000.0 in 2023, then surged by 37211350.0% to $744.2 million in 2024, then slumped by 100.0% to $8000.0 in 2025, then surged by 3224125.0% to $257.9 million in 2026.
• Business Quant data shows CYTK's Change in Acquisitions & Divestments at $257.9 million in Q1 2026, $8000.0 in Q4 2025, and $1000.0 in Q3 2025.